New Drug Rules Aim To Speed Generics President Bush today announced new regulations to hasten the pace at which generic drugs are brought to market, a measure the administration says will save $3.5 billion annually after it takes effect Aug. 18.
RNAi Firms Stake Their Claims First there was gene splicing. Next came monoclonal antibodies. And now, RNA interference, or gene silencing, has taken the scientific community by storm. Reportedly, RNA interference technology has revolutionized the practice of molecular biology – and the excitement it has generated continues to mount
Get new actionable insights and updates from BiotechBlog
